Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 6/20 | 0.57 |
| ▸ | ARG1 | P05089 | 1/20 | 0.52 |
| ▸ | ARG2 | P78540 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | NOS2 | P35228 | 3/20 | 0.46 |
| ▸ | NOS1 | P29475 | 2/20 | 0.46 |
| ▸ | NOS3 | P29474 | 1/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.43 |
| ▸ | GRM6 | O15303 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.43 |
| ▸ | GSR | P00390 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.43 |
| ▸ | GRM5 | P41594 | 1/20 | 0.43 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.43 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.43 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbocysteine SCHEMBL6762355 | 0.98 | BHMT (0.59) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL20854 | 0.98 | BHMT (0.59) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL9236855 | 0.98 | BHMT (0.59) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL69149 | 0.98 | BHMT (0.59) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL15546452 | 0.95 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL19614495 | 0.95 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL19614508 | 0.95 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL15545269 | 0.95 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL19614507 | 0.95 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A | |
| Carbocysteine SCHEMBL19614546 | 0.95 | BHMT (0.57) | BHMTARG1ARG2CYP2D6HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199710-A1 | BIOACTIVE POLYPEPTIDES AND METHODS RELATED THERETO | LINCOLN UNIVERSITY (NZ) | 2024-06-20 | — | — | US | disclosed |
| US-11827690-B2 | ApoC-II mimetic peptides | NOVO NORDISK INC. (DK) | 2023-11-28 | — | — | US | disclosed |
| CN-116783296-A | Screening platform for recruiting guide RNAs of ADAR | 小利兰·斯坦福大学托管委员会 | 2023-09-19 | — | — | CN | disclosed |
| WO-2023101566-A1 | GENETIC MARKERS AND METHODS RELATED THERETO | LIVESTOCK IMPROVEMENT CORPORATION LIMITED (NZ) | 2023-06-08 | — | — | WO | disclosed |
| US-20230145729-A1 | INDOLE DITERPENE BIOSYNTHESIS | GRASSLANZ TECHNOLOGY LIMITED (NZ) | 2023-05-11 | — | — | US | disclosed |
| EP-4125340-A1 | INDOLE DITERPENE BIOSYNTHESIS | Grasslanz Technology Limited (NZ) | 2023-02-08 | — | — | EP | disclosed |
| WO-2023277709-A1 | GENETIC MARKERS AND METHODS RELATED THERETO | DAIRY GOAT CO-OPERATIVE (N.Z.) LIMITED (NZ) | 2023-01-05 | — | — | WO | disclosed |
| CN-114829383-A | Bioactive agents and methods relating thereto | 阿罗阿生物外科有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114126661-A | Biological materials and methods related thereto | 奥克兰服务有限公司 | 2022-03-01 | — | — | CN | disclosed |
| EP-3920971-A1 | BIOMATERIALS AND METHODS RELATED THERETO | Auckland Uniservices Limited (NZ) | 2021-12-15 | — | — | EP | disclosed |
| US-20210324043-A1 | ApoC-II Mimetic Peptides | CORVIDIA THERAPEUTICS, INC. | 2021-10-21 | — | — | US | disclosed |
| WO-2021201700-A1 | INDOLE DITERPENE BIOSYNTHESIS | GRASSLANZ TECHNOLOGY LIMITED (NZ) | 2021-10-07 | — | — | WO | disclosed |
| US-11136372-B2 | ApoC-II mimetic peptides | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH & HUMAN SERVICES (US) | 2021-10-05 | — | — | US | disclosed |
| WO-2021040537-A1 | BIOACTIVE POLYPEPTIDES AND METHODS RELATED THERETO | ECOLIBRIUM BIOLOGICALS HOLDINGS LIMITED (NZ) | 2021-03-04 | — | — | WO | disclosed |
| WO-2020246900-A1 | BIOACTIVE AGENTS AND METHODS RELATED THERETO | AROA BIOSURGERY LIMITED (NZ) | 2020-12-10 | — | — | WO | disclosed |
| WO-2020162765-A1 | BIOMATERIALS AND METHODS RELATED THERETO | AUCKLAND UNISERVICES LIMITED (NZ) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020154631-A1 | DYNAMICS WITHIN SUPRAMOLECULAR 1KVAV MATRICES ENHANCE FUNCTIONAL MATURATION OF HUMAN IPSCS-DER1VED NEURONS AND REGENERATION | NORTHWESTERN UNIVERSITY (US) | 2020-07-30 | — | — | WO | disclosed |
| US-20200140522-A1 | ApoC-II Mimetic Peptides | NOVO NORDISK A/S (DK) | 2020-05-07 | — | — | US | disclosed |
| WO-2018136803-A1 | APOC-II MIMETIC PEPTIDES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMETN OF HEALTH & HUMAN SERVICES (US) | 2018-07-26 | — | — | WO | disclosed |
| CN-103945871-A | Fusion proteins for the treatment of metabolic diseases | NOVARTIS AG | 2014-07-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230145729-A1 | INDOLE DITERPENE BIOSYNTHESIS | INMT, PNMT, COASY | BHMT 367/4885ARG1 3568/4885ARG2 2529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.